B. Riley Asset Management Acquires Rights to Manage Dialectic Hedge Funds
- Press Release
I, Andy DSilva , certify that this report reflects my personal beliefs about this company and that no portion of my compensation was, is or will be directly or indirectly related to the specific recommendations or views discussed in this report.
Initiated Coverage on 07/23/2015 with Buy Rating and Price Target of $5.25
|Ratings Distribution as of April 28, 2017|
|Rating||Number of Companies||Percent of Total||Number of Companies with
Investment Banking Relationships
|Percent of Total|
The company sells equipment that emits radiation and could pose health risks to end users. Additionally, the company provides a service using its own and third party equipment that emits radiation and could pose health risks to the end users. Nuclear imaging services requires the injection of radiopharmaceuticals into patients' bloodstream. Radiopharmaceuticals also emit radiation signals that could pose health risks to end users.